Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Evolocumab in Asymptomatic Carotid Artery Stenosis
NCT03931161Phase 4Unknown
- Sponsor
- Imperial College Healthcare NHS Trust
- Start
- Sep 2019
- Primary completion
- May 2023
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in carotid artery stenosis (CAS) comparing Placebo with Evolocumab (2 arms). Primary endpoint: Change in lipid-rich necrotic core at 12 months. Status: unknown.
02
Drugs
evolocumab
03
Conditions
carotid artery stenosis (CAS)
Beyond the preview
Go deeper on NCT03931161.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03931161.